Patent · US Active

Factor VII: remodeling and glycoconjugation of Factor VII

US8008252B2 · kind B2 · utility

27Cited by

149References

87Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Shawn DeFrees · North Wales, US
David A. Zopf · Strafford, US
Robert J. Bayer · San Diego, US
Caryn Bowe · Doylestown, US
David Hakes · Willow Grove, US
Xi Chen · Newton, US

Key dates

Filing date	Apr 9, 2003
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Nov 4, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21021
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.